| Issue Date | Title | Author(s) |
| 2018-08 | MASTL overexpression promotes chromosome instability and metastasis in breast cancer. | Rogers, S; McCloy, RA; Parker, BL; Gallego-Ortega, D; Law, AMK; Chin, VT; Conway, JRW; Fey, D; Millar, EKA; O'Toole, S; Deng, N; Swarbrick, A; Chastain, PD; Cesare, AJ; Timpson, P; Caldon, CE; Croucher, DR; James, DE; Watkins, DN; Burgess, A |
| 2016-12-08 | MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. | Young, AIJ; Law, AMK; Castillo, L; Chong, S; Cullen, HD; Koehler, M; Herzog, S; Brummer, T; Lee, EF; Fairlie, WD; Lucas, MC; Herrmann, D; Allam, A; Timpson, P; Watkins, DN; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR |
| 2020-06 | Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression. | Toscan, CE; Jing, D; Mayoh, C; Lock, RB |
| 2017-07 | The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. | Law, AMK; Lim, E; Ormandy, CJ; Gallego-Ortega, D |
| 2021-08-01 | Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma. | Xiao, L; Somers, K; Murray, J; Pandher, R; Karsa, M; Ronca, E; Bongers, A; Terry, R; Ehteda, A; Gamble, LD; Issaeva, N; Leonova, KI; O'Connor, A; Mayoh, C; Venkat, P; Quek, H; Brand, J; Kusuma, FK; Pettitt, JA; Mosmann, E; Kearns, A; Eden, G; Alfred, S; Allan, S; Zhai, L; Kamili, A; Gifford, AJ; Carter, DR; Henderson, MJ; Fletcher, JI; Marshall, G; Johnstone, RW; Cesare, AJ; Ziegler, DS; Gudkov, AV; Gurova, KV; Norris, MD; Haber, M |
| 2021-07 | First experimental evaluation of multi-target multileaf collimator tracking during volumetric modulated arc therapy for locally advanced prostate cancer. | Hewson, EA; Dipuglia, A; Kipritidis, J; Ge, Y; O'Brien, R; Roderick, S; Bell, L; Poulsen, PR; Eade, T; Booth, JT; Keall, PJ; Nguyen, DT |
| 2016-07-15 | Single-cell profiling approaches to probing tumor heterogeneity. | Khoo, BL; Chaudhuri, PK; Ramalingam, N; Tan, DSW; Lim, CT; Warkiani, ME |
| 2016-12-12 | Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. | Torchia, J; Golbourn, B; Feng, S; Ho, KC; Sin-Chan, P; Vasiljevic, A; Norman, JD; Guilhamon, P; Garzia, L; Agamez, NR; Lu, M; Chan, TS; Picard, D; de Antonellis, P; Khuong-Quang, D-A; Planello, AC; Zeller, C; Barsyte-Lovejoy, D; Lafay-Cousin, L; Letourneau, L; Bourgey, M; Yu, M; Gendoo, DMA; Dzamba, M; Barszczyk, M; Medina, T; Riemenschneider, AN; Morrissy, AS; Ra, Y-S; Ramaswamy, V; Remke, M; Dunham, CP; Yip, S; Ng, H-K; Lu, J-Q; Mehta, V; Albrecht, S; Pimentel, J; Chan, JA; Somers, GR; Faria, CC; Roque, L; Fouladi, M; Hoffman, LM; Moore, AS; Wang, Y; Choi, SA; Hansford, JR; Catchpoole, D; Birks, DK; Foreman, NK; Strother, D; Klekner, A; Bognár, L; Garami, M; Hauser, P; Hortobágyi, T; Wilson, B; Hukin, J; Carret, A-S; Van Meter, TE; Hwang, EI; Gajjar, A; Chiou, S-H; Nakamura, H; Toledano, H; Fried, I; Fults, D; Wataya, T; Fryer, C; Eisenstat, DD; Scheinemann, K; Fleming, AJ; Johnston, DL; Michaud, J; Zelcer, S; Hammond, R; Afzal, S; Ramsay, DA; Sirachainan, N; Hongeng, S; Larbcharoensub, N; Grundy, RG; Lulla, RR; Fangusaro, JR; Druker, H; Bartels, U; Grant, R; Malkin, D; McGlade, CJ; Nicolaides, T; Tihan, T; Phillips, J; Majewski, J; Montpetit, A; Bourque, G; Bader, GD; Reddy, AT; Gillespie, GY; Warmuth-Metz, M; Rutkowski, S; Tabori, U; Lupien, M; Brudno, M; Schüller, U; Pietsch, T; Judkins, AR; Hawkins, CE; Bouffet, E; Kim, S-K; Dirks, PB; Taylor, MD; Erdreich-Epstein, A; Arrowsmith, CH; De Carvalho, DD; Rutka, JT; Jabado, N; Huang, A |
| 2016-06 | Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis. | Carter, DR; Sutton, SK; Pajic, M; Murray, J; Sekyere, EO; Fletcher, J; Beckers, A; De Preter, K; Speleman, F; George, RE; Haber, M; Norris, MD; Cheung, BB; Marshall, GM |
| 2018-11-15 | Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma. | Wei, JS; Kuznetsov, IB; Zhang, S; Song, YK; Asgharzadeh, S; Sindiri, S; Wen, X; Patidar, R; Najaraj, S; Walton, A; Auvil, JMG; Gerhard, DS; Yuksel, A; Catchpoole, D; Hewitt, SM; Sondel, PM; Seeger, R; Maris, JM; Khan, J |
